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ABSTRACT
Developmental gynecology uses methods practiced in auxology — the science of human ontogenetic development.  
An important and jointly used concept in gynecology and auxology is the concept of developmental age, which, unlike 
calendar age, is a measure of the biological maturity of the organism, indicating the stage of advancement in the develop-
ment of certain features or body systems. Developmental age assessment methods include: a) morphological (somatic) 
age — body height and weight, b) secondary sex characteristics — breast in girls, genitalia (penis and testes) in boys, and 
pubic hair in both sexes, c) bone age — hand and wrist x-ray, and d) dental age. An important marker of developmental 
age is also age at menarche, treated as a late indicator of puberty in girls. All of these methods are useful in the context of 
assessing regularity and disorders of puberty, such as delayed puberty. The paper discusses developmental age assessment 
methods that can be used to diagnose delayed puberty as well as the causes of delayed puberty in girls. It should be empha-
sized that in assessing the process of physical development of a given individual, the cooperation of specialists in the field 
of developmental gynecology, pediatrics, auxology, dentistry, endocrinology, and dietetics would be the most desirable.
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INTRODUCTION
Puberty is a period of dynamic human development 
leading to sexual maturity. It is a transition period between 
childhood and adulthood, which takes place in several se-
quential stages controlled by neuroendocrine factors. It is 
characterized by the development of secondary and tertiary 
sexual characteristics and acceleration of linear growth, 
referred to as adolescent growth spurt [1]. The first exter-
nal symptom of puberty in girls is breasts development 
(between 9–13 years of age). A relatively late event during 
puberty is menarche, which usually occurs about 1.2 to 
1.3 years after reaching a maximum rate of linear growth 
(peak height velocity, PHV) [2]. In recent years the mean age 
at menarche in Poland ranged from 12.5 to 13 years [3, 4]. 
METHODS FOR ASSESSING DEVELOPMENTAL 
AGE
In both auxology and developmental gynecology, 
an important concept is developmental (biological) age, 
understood as progress toward a mature state, or, in other 
words, as the degree of physiological development of the 
organism. Signiﬁcant interindividual variance exists for 
the level (magnitude of change), timing (onset of change), 
and tempo (rate of change) of biological maturation. 
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An individual’s developmental age may proceed at a different 
pace than the calendar age. It depends, to a large extent, on 
the genetic background, sex, environmental factors, body 
type, or ethnicity [5]. One of the most important reasons for 
assessing developmental age is to see how far it varies from 
chronological age. Estimation of differences between these 
two traits helps to identify signs of abnormal development, 
which may be precocious or delayed puberty [6]. Devel-
opmental age can be measured in several ways, including 
physical (morphological) maturity, stage of advancement in 
the development of secondary sex characteristics, skeletal 
maturity, and dental maturity. The physical maturity is as-
sessed on the basis of height and weight. However, a more 
precise method of assessing physical maturity is the estima-
tion of height velocity [7]. An informative marker of physical 
maturity during adolescence is both the age of onset of 
adolescent growth spurt (Age at Take Off, ATO), i.e. the mo-
ment when velocity of body height growth is the smallest, 
and the age when velocity of body height growth is the 
highest (Age at Peak Height Velocity, APHV) [2]. The take-off 
of the growth spurt (TO) in girls appears on average around 
8–9 years, about 2 years earlier than in boys. Peak height ve-
locity (PHV) occurs in girls aged 11.5 years, and in boys aged 
13.5 [2, 3]. In the assessment of developmental age during 
puberty, the markers of secondary sexual characteristics 
appear to be one of the most important. They are classified 
with the use of Tanner stages: breast stage in girls, genital 
stage in boys and pubic hair stage in both sexes [1]. Tanner 
stages (scores) describe the visible signs of sexual matura-
tion. Stage one describes the absence of any symptoms of 
puberty, while stage five presents a fully developed form of 
assessed traits [5]. In girls, onset of puberty is defined as the 
first sign of breast development (B2 on the Tanner scale) and 
not pubic hair, because the latter does not necessarily her-
ald activation of the gonads, and may be due to increasing 
secretion of adrenal androgens (adrenarche). Furthermore, 
in both gynecological practice and auxology, the age of the 
first menstruation, i.e. menarche, is an invaluable marker 
of the tempo of development. Skeletal age is usually esti-
mated using hand-wrist radiograph, based on the appear-
ance of individual bones or the degree of fusion of epiphy-
seal plate [8]. Another marker available for developmental 
age estimation is the dental age, based on tooth eruption 
or tooth mineralization assessed from dental radiographs. 
In each of the methods described, the child’s status is com-
pared with age-related norms. It is then assumed that the 
developmental age is the mean chronological age corre-
sponding to her or his developmental status [7]. 
CAUSES OF DELAYED PUBERTY IN GIRLS
Delayed puberty in girls is defined  as a lack of evidence 
of breast development by the age of 13 years and amen-
orrhea 5 years after the start of the puberty with no full 
secondary sex features development [9]. It is also defined 
as the lack of signs of puberty at two standard deviations 
above the mean age for the general population [10]. De-
layed puberty occurs in 3% of the population, more often 
in boys than girls. It may result from constitutional delay of 
puberty, hypogonadotropic or hypergonadotropic states, 
existing chronic diseases (as a secondary symptom), or in-
tense physical exercise [11].
Delayed puberty is most often due to a functional de-
fect in the production of gonadotropin-releasing hormone 
(GnRH). Among the reasons for the abnormal secretion of 
GnRH from the hypothalamus is the constitutional delay 
of growth and puberty (CDGP), undernutrition or chronic 
illness. The result of GnRH deficiency is inadequate ovar-
ian steroid secretion. Other causes of delayed puberty 
include a variety of hypothalamic, pituitary, and gonadal 
disorders [12].
In most cases, delayed puberty is caused by the constitu-
tional delay of growth and puberty (CDGP) and is considered 
a temporary form of hypogonadotropic hypogonadism 
[10, 13]. CDGD refers to a slower developmental tempo in 
children with no physical abnormalities causing the delay. 
These children start puberty late and are most often of 
short stature [5]. CDPG is 10 times more common in boys 
than girls and does not require advanced medical evalua-
tion and treatment. 
Many authors are emphasizing the influence of nutri-
tional status and diet on estradiol concentration and pu-
berty course. A common diagnosis for very slim girls with 
delayed puberty is functional gonadotropin deficiency. It is 
worth mentioning that this unusual thinness can result from 
either eating disorders, such as anorexia nervosa, or intense 
physical activity without enough caloric intake to maintain 
normal weight. Girls practicing: competitive swimming, bal-
let dancing, and gymnastics show the high risk of delayed 
menarche [6]. Intensive physical activity is connected with 
delayed puberty because of negative energetic balance, 
special diet, and corticotropic axis stimulation in increased 
stress leading to gonadoliberin excretion disturbances [13]. 
The relationship between the percentage of fat tissue and 
the dynamics of the puberty process has been demonstrat-
ed in girls [3, 14]. Leptin secreted by adipose tissue is a key 
factor affecting the age of puberty onset since it has been 
shown to have a direct effect on the secretion of gonado-
tropins and gonadotropin releasing hormone (GnRH) [15]. 
Leptin receptors are identified in the hypothalamus, an-
terior pituitary gonadotropic cells and ovarian follicular 
cells. Abnormal leptin level in underweight girls with a low 
percentage of body fat generally result in amenorrhea 
and delayed puberty [16]. The same explanation is likely 
for girls who are very thin due to chronic illness. In gen-
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eral, the negative energy balance can disturb the pattern 
of pulsatile gonadotropin secretion leptin/neuropeptide Y 
or using other neurotransmitters. Quantitative and qualita-
tive nutritional status, BMI, fat tissue mass, and leptin blood 
level are important features in intense systemic and chronic 
disease state. A lot of chronic diseases are connected to 
delayed or arrest in the puberty stage which depends on 
the point at which the disease occurred. Malnourishment, or 
low BMI resulting from negative energy balance can cause 
the disturbance of pulsatile gonadoliberin secretion, as 
well as: a) gastrointestinal diseases: celiac disease should 
be considered when unexplained delayed of puberty and 
growth is observed, positive diagnosis should be confirmed 
by detection of transglutaminase antibodies and atrophic 
villi in jejunal biopsy; b) inflammatory bowel disease might 
be connected with delayed puberty in case of steroid ther-
apy and weight loss; c) chronic lung diseases like cystic 
fibrosis can cause the same deficiencies which are caused 
mostly by malnourishment; d) chronic renal failure prior to 
transplantation or nephrotic syndrome sensitive to steroids; 
e) thalassemia major or sickle cell anemia can inhibit puberty 
by the deposition of iron in pituitary gland [9, 13].
Delayed puberty can also be caused by hypergonado-
tropic hypogonadism (primary ovarian failure), which may 
result from either karyotype abnormality (Turner syndrome) 
or autoimmune destruction of the ovaries, associated with 
conditions such as type 1 diabetes mellitus, hypothyroidism, 
Addison disease or hypoparathyroidism. The risk group of 
primary ovarian failure also includes girls undergoing total 
body irradiation or chemotherapy during the treatment 
of various forms of malignancies [9]. Hypogonadotropic 
hypogonadism is defined as lack of ability of proper pro-
duction of gonadotropins — FSH and LH. This deficiency 
can be caused by isolated pituitary gonadotropic cells ab-
normality or coexistent with other pituitary cells changes 
concerning infundibulum or hypothalamus with a change 
in pulsatile secretion of gonadoliberin. Isolated idiopathic 
hypogonadotropic hypogonadism (IHH) is often mistaken 
by CDGP because in both cases there is a low level of ste-
roid hormones and gonadotropins. In CDGP, the response 
to gonadotropin agonists plays an important role in the 
differential diagnosis. Some girls with delayed puberty, 
usually with coexisting delayed growth and short stature 
(-2 SD on average height according to age) do not suffer 
from CDGP, but just a variation of development time. In this 
case, spontaneous beginning of puberty and acceleration of 
linear growth are observed. Hence, it is hard to differentiate 
between CDGP and IHH, even if some symptoms can help 
with proper treatment choice. The main aim of the clinical, 
radiological and biological examination is to eliminate the 
somatic disease. It is important to differentiate the typical 
growth hormone deficiency. In the case of CDGP, short stat-
ure and slow tempo of linear growth are well correlated with 
bone age, which is connected with delayed puberty but not 
chronological age. The growth hormone secretion might be 
low at a basal level whereas stimulation tests give positive 
results at a suboptimal level, which in fact corresponds to 
prepubertal period. The hormone level differences do not 
occur, which is confirmed by the tests of pituitary func-
tion. In this case systematic radiological examinations e. g. 
MRI do not show the signs of neoplastic process or infiltra-
tion to other organs [13]. Other causes of inappropriate 
gonadotropin secretion include, inter alia: organic direct 
gonadotropin deficiency, neoplastic origin of idiopathic 
hypogonadotropic hypogonadism (IHH), congenital go-
nadotropins deficiency (is connected with low FSH and LH 
level, compatible bone age and normal stature and normal 
karyotype; several genes connected with this condition 
have been identified), primary GnRH deficiency (after con-
firmation of GnRH deficiency, treatment with recombinant 
growth hormone will trigger puberty, which implies the 
need of IGF-1 treatment. IGF-1 is proved to enhance LH 
and FSH ovarian stimulation), Prader-Willi Syndrome, Lau-
rence-Moon-Bardet-Biedl syndrome, Kallmann syndrome 
(uncommon in females, probably because the most com-
mon form, due to a defective KAL1 gene, is X-linked [9]. 
Delayed puberty may also be observed in patients with 
FSH or LH receptor coding gene mutation. Deactivating 
mutation of FSH receptor is connected with premature ovar-
ian failure or primary amenorrhea. The size of ovaries is at 
a normal level and pathological examination shows multiple 
growing ovarian follicles. Several cases were observed in 
homozygotic XX females with primary amenorrhea, who 
developed sex features and elevated LH but normal FSH 
levels and ovarian vesicles with no corpus luteum. In case 
of absence of response on gonadoliberin stimulation test 
and pulsatile gonadoliberin application, we can consider 
gonadoliberin receptor gene mutation on chromosome 4. 
There are reports about few autosomal recessive forms of 
isolated IHH with that kind of mutations. However, this phe-
notype occurs in various forms — from partial to full [9, 13]. 
Only a few mutations inactivating FSH β subunit was iden-
tified. The gene is situated in Xp21u in a female. One mu-
tation presents with only partially developed secondary 
sexual characteristics and two with primary amenorrhea. 
DAX1 gene mutation (gene causing congenital adrenal 
dysplasia in case of X-linked inheritance). DAX1 is transcrip-
tion factor from “orphan nuclear receptors” family, which 
take part in differentiation process of adrenal glands, hypo-
thalamus, pituitary and gonads. Mutation of this gene con-
nected with the X chromosome in men leads to congenital 
hypoplasia with insufficiency in the neonatal period and 
delayed IHH that is manifesting during adolescence. There 
are reports about isolated IHH in women that might corre-
665
Magdalena Durda-Masny et al., Delayed puberty in girls
www. journals.viamedica.pl/ginekologia_polska
spond to mild male HH connected with congenital adrenal 
hypoplasia [13]. 
The analysis of delayed puberty with hypogonadotropic 
hypogonadism of various etiologies reveals how important 
the molecular tests are in the process of diagnosis [17–20].
The hypergonadotropic hypogonadism with character-
istic elevated FSH and/or LH level caused by ovarian failure 
requires rule out of female phenotype, uterine and ovar-
ian functional tissue ultrasonographical verification, and 
karyotype assay [9, 13]. The examples of such conditions 
are gonadal dysgenesis with a chromosomal aberration. 
The most frequent cause of primary ovarian failure is Turner 
syndrome in classic monosomy 45, XO form with female 
phenotype (poor growth, sexual infantilism, etc.). Swyer syn-
drome with 46, XY karyotype is characterized by the female 
phenotype, female internal genital genitalia (Mullerian duct 
derivatives), normal or bigger height, gonadal dysgenesis, 
sexual infantilism, and primary amenorrhea. Ovarian dys-
genesis with normal 46, XX karyotype is characterized by 
diminished ovarian size and female phenotype. An interest-
ing example of hypogonadotropic hypogonadism is Per-
rault syndrome as autosomal recessive ovarian dysgenesis 
coexisting with deafness. The diagnostic evaluation must 
include a detailed physical examination, height and bone 
maturation, measurements of general hematological and 
biochemical parameters, gonadotropins, sex steroids, pro-
lactin, thyroid hormones, growth hormone and growth 
factors, and personal and familial antecedents [11].
It is important to conduct diagnosis per exclusionem - 
diagnosis by exclusion - clinical examination with assessing 
the features of puberty, regular checkups, puberty progres-
sion) and biochemical examination including estradiol/tes-
tosterone, prolactin, GnRH antagonist, hCG level (hCG/hMG), 
hands X-ray, ultrasonography of uterine and ovaries, head 
CT or MRI if necessary. 
THE ROLE OF DEVELOPMENTAL AGE 
ASSESSMENT IN GIRLS WITH DELAYED PUBERTY
The age at puberty depends on the interaction between 
genetic and environmental factors, which is the reason for 
the large phenotypic variance of its start and course. Thus, 
in the diagnosis of delayed puberty, the calendar age is not 
a sufficient measure of the level of advancement in biologi-
cal development. The status of development of a child is 
usually assessed in relation to events that take place during 
the progress of growth. Hence, in the assessment of the bio-
logical age, various parameters are taken into account, such 
as bone age, age at menarche, body height, body mass, but 
also dental age [21]. While such markers of biological age as 
body height or weight, age at menarche or the level of devel-
opment of secondary sexual characteristics assessed using 
the Tanner scale are known in gynecological practice, dental 
age is still used to a small extent. Many studies have demon-
strated that sex hormones have an important role in osteo-
genic differentiation and hard tissue metabolism [22, 23]. 
They have an effect on facial and cranial base growth and 
are odontogenic [24].  However, their effects on dental de-
velopment have not been clearly described in the literature. 
More than half a century ago, Garn et al. reported that chil-
dren more advanced somatically or sexually were more ad-
vanced dentally, while children with retarded development 
showed delayed dental maturation but to a lesser degree 
than skeletal maturation [25]. The results were based on 
the systematic exploration of tooth formation in a variety of 
endocrine and non-endocrine developmental retardations 
and precocities. Two decades later, Demirjian et al. stated 
that the mechanisms controlling dental development do 
not depend on somatic and/or sexual maturity [26]. In their 
study, the age at which French-Canadian girls attained 90% 
of the dental development showed no significant relation-
ships with the other maturity indicators. 
In idiopathic precocious puberty, Roberts et al. found 
that dental ages were delayed in relation to their chronologi-
cal age in children [27]. Conversely, the recent study by Lee 
et al. revealed early maturation of the mandibular teeth in 
girls with central precocious puberty [28]. As far as delayed 
puberty is concerned, Gaethofs et al. observed  significant 
retardation of dental maturation in boys with CDGP. How-
ever, it should be emphasized that, the examined group was 
small and consisted of only 8 subjects [29].
As reminded by Różyło-Kalinowska et al., the assess-
ment of dental maturity can be a valuable method for initial 
assessment of the level of skeletal maturity of a child [30]. 
However, it cannot be used as the only measure of devel-
opment, especially in atypically developing patients, such 
as those with endocrine disorders, congenital diseases, 
or other signs and symptoms. Dental age is most com-
monly assessed with the use of the Demirjian method [31]. 
However, this method has some concerns. As mentioned 
above, the reference group was French-Canadian, and the 
possible effect of ethnicity was not taken into account. 
Another problem associated with the Demirjian method is 
that it does not include third permanent molars, therefore 
it cannot be used in young adults. According to Fudalej et 
al., the Demirjian method overestimates the dental age of 
Polish children of about 12 months [32]. Wites et al. stated 
that the dental age slightly proceeds the chronological age 
during puberty [33]. Zatylna et al. proved that the dental age 
assessed by Demirjian’s method differs from the chronologi-
cal age, more significantly in girls [34]. Dental maturation 
has been shown to be mildly but consistently delayed in 
patients with delayed development [35]. Therefore, in order 
to assess the abnormalities of the puberty process in a com-
prehensive way, apart from specialists in developmental 
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gynecology, pediatrics, auxology or endocrinology, it would 
be worth including dentists who would add another marker 
of developmental age, which is dental age.
SUMMARY
Evaluation of developmental age during puberty using 
as many methods as possible (morphological age, secondary 
sexual characteristics, menarche age, bone age, dental age) al-
lows the most comprehensive indication of signs of abnormal 
development, such as delayed puberty. Relationship between 
sexual maturation, skeletal age, dental age, general health, and 
a lifestyle  support the need for collaboration between pediatri-
cians, endocrinologists, pediatric gynecologists, dieticians and 
dentists in the management of irregularities of age at puberty.
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